Therapeutic effect of oxyberberine on obese non-alcoholic fatty liver disease rats
Qiaoping Li(Guangzhou University of Chinese Medicine), Jianhui Xie(Shanghai Medical College of Fudan University), Hanbin Chen(Peking University), Xiaobo Yang(Guangzhou University of Chinese Medicine), Yucui Li(Guangzhou University of Chinese Medicine), Ziren Su(Guangzhou University of Chinese Medicine), Yuhong Liu(Guangzhou University of Chinese Medicine), Jian-Nan Chen(Guangzhou University of Chinese Medicine), Huifang Zeng(National Clinical Research), Yaoxing Dou(Guangzhou University of Chinese Medicine), Ziwei Huang(Stomatology Hospital), Xiaoqi Huang(Guangzhou University of Chinese Medicine)
Cited by 54
Related Papers
Inhibition of CXCR4 with the novel RCP168 peptide overcomes stroma-mediated chemoresistance in chronic and acute leukemias
|Molecular Cancer Therapeutics|2006|186
Structural and Functional Characterization of Human CXCR4 as a Chemokine Receptor and HIV-1 Co-receptor by Mutagenesis and Molecular Modeling Studies
|Journal of Biological Chemistry|2001|138
Bio-template synthesis of Mo-doped polymer carbon nitride for photocatalytic hydrogen evolution
|Applied Catalysis B: Environmental|2019|133
Response Efficacy of PD-1 and PD-L1 Inhibitors in Clinical Trials: A Systematic Review and Meta-Analysis
|Frontiers in Oncology|2021|125
Exploring the Stereochemistry of CXCR4-Peptide Recognition and Inhibiting HIV-1 Entry with d-Peptides Derived from Chemokines
|Journal of Biological Chemistry|2002|117